BACKGROUND: Safe and effective target choice of cell transplantation is an important direction for clinical research. Whether the point(s) or region(s) exist in the brain that play an important role in maximizing positive impact on the neural network to play and then repair, which is one of the key topics, must be studied priority by the forerunners.
OBJECTIVE: To explore the objectivity, authenticity and practicality of the theory of key point for neural network restoration (KPNNR) related to cell intracranial transplantation by clinical data analysis.
METHODS: Between May 2003 and January 2009, a total of 631 patients with central nervous system diseases underwent the olfactory ensheathing cell (OEC) graft into KPNNR. Of them, 609 patients had complete clinical information: 392 males and 217 females. Their age ranged from 1.2 to 84 (mean 42.87±19.64) years and course of disease was from 0.4 to 35 with an average of (5.11±5.46) years. Disease distribution: 432 patients suffered from amyotrophic lateral sclerosis, 110 cases of cerebral palsy, 25 cases of multiple sclerosis, 12 cases of ataxia, 7 cases of multiple system atrophy, 6 cases of hereditary spastic paraplegia, 6 cases of persistent vegetable state, 2 cases of dementia, 2 cases of sequela of cerebral anoxia, 2 cases of Parkinsonism plus syndrome, 2 cases of non-specific encephalitis sequelae, 1 case of adrenoleukodystrophy, 1 case of kernicterus sequelae, and 1 case of corticobasal degeneration. The patients came from 75 countries or regions.
RESULTS AND CONCLUSION: The patients were followed up for 2 to 8 weeks, with an average of four weeks, after cell transplantation. Among 609 cases, 526 cases had neurological function improvements at different levels. The overall improvement rate was 86.37%. Of them, the effective rate in amyotrophic lateral sclerosis was 87.96%. The improvement rate in cerebral palsy was 82.7%, especially, 4 patients who accompanied with epilepsy reduced attack significantly. The improvement rate in ataxia was 83.3%. The improvement rate in hereditary spastic paraplegia was 83.3%. Perioperative adverse events occurred at a total of 33 cases, with the occurrence rate of 5.4%, mainly headache, fever and so on, which were cured by symptomatic treatment. Results suggest that the therapeutic method of OEC transplanted into KPNNR is simple, safe, and feasible, which can improve the function of patients with a variety of central nervous system of neurological diseases and/or slow down the progressive deterioration of some degenerative diseases.